La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Centene Résultats passés

Passé contrôle des critères 2/6

Centene a connu une croissance annuelle moyenne de ses bénéfices de 15.8%, tandis que le secteur Healthcare a vu ses bénéfices augmenter de en hausse à 7.1% par an. Les revenus ont augmenté de en hausse à un taux moyen de 14.7% par an. Le rendement des capitaux propres de Centene est 10.3% et ses marges nettes sont de 2%.

Informations clés

15.8%

Taux de croissance des bénéfices

11.4%

Taux de croissance du BPA

Healthcare Croissance de l'industrie	8.5%
Taux de croissance des recettes	14.7%
Rendement des fonds propres	10.3%
Marge nette	2.0%
Prochaine mise à jour des résultats	25 Oct 2024

Mises à jour récentes des performances passées

Centene (NYSE:CNC) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Aug 02

Recent updates

Centene (NYSE:CNC) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Aug 02

Here's Why We Think Centene (NYSE:CNC) Is Well Worth Watching

Jun 22

A Piece Of The Puzzle Missing From Centene Corporation's (NYSE:CNC) Share Price

Jun 04

Returns At Centene (NYSE:CNC) Appear To Be Weighed Down

May 14

These 4 Measures Indicate That Centene (NYSE:CNC) Is Using Debt Reasonably Well

Apr 26

Centene Corporation Still An Opportunity With An A-Grade Valuation

Mar 31

If EPS Growth Is Important To You, Centene (NYSE:CNC) Presents An Opportunity

Mar 15

Market Still Lacking Some Conviction On Centene Corporation (NYSE:CNC)

Feb 08

Centene: Stay Defensive Amid Economic Uncertainty With This Low-Beta Bargain

Jan 22

Is Centene (NYSE:CNC) Using Too Much Debt?

Jan 21

Centene: Overlooked Healthcare Giant

Nov 21

Does Centene (NYSE:CNC) Deserve A Spot On Your Watchlist?

Nov 10

Centene: Solid Performance With Positive Outlook, But Limited Upside Potential

Oct 26

These 4 Measures Indicate That Centene (NYSE:CNC) Is Using Debt Reasonably Well

Oct 22

Decoding Centene: Why I Think It's Undervalued

Oct 10

If EPS Growth Is Important To You, Centene (NYSE:CNC) Presents An Opportunity

Jul 31

Centene: Results Impress But Buyers Aren't Swarming Yet

Jul 27

Centene (NYSE:CNC) Has A Pretty Healthy Balance Sheet

Jul 12

Centene (NYSE:CNC) Seems To Use Debt Quite Sensibly

Apr 10

Centene Non-GAAP EPS of $0.86 beats by $0.02, revenue of $35.56B beats by $190M

Feb 07

With EPS Growth And More, Centene (NYSE:CNC) Makes An Interesting Case

Jan 27

Centene (NYSE:CNC) Seems To Use Debt Rather Sparingly

Dec 27

Centene: Once Again, With Quality, Now A 'Buy'

Dec 23

Centene appoints new leadership; Ken Fasola President of Centene, Dave Thomas CEO of Medicaid

Dec 14

An Intrinsic Calculation For Centene Corporation (NYSE:CNC) Suggests It's 50% Undervalued

Nov 11

Is Now The Time To Put Centene (NYSE:CNC) On Your Watchlist?

Oct 26

Centene Q3 2022 Earnings Preview

Oct 24

Centene: Future Growth Will Exceed Market Expectations

Oct 14

Centene: A Chaos Stock

Sep 28

Does Centene (NYSE:CNC) Have A Healthy Balance Sheet?

Sep 20

Centene falls 7%, most since April 2021, on surging volume

Sep 14

If EPS Growth Is Important To You, Centene (NYSE:CNC) Presents An Opportunity

Jul 28

Centene Q2 2022 Earnings Preview

Jul 25

Centene Keeps Overdelivering - But Is Expensive

Jul 11

Is Centene (NYSE:CNC) Using Too Much Debt?

Jun 16

Centene: Solid Q122 Earnings For Health Insurer Helps Make Buy/Hold Case

Apr 28

Ventilation des recettes et des dépenses

Comment Centene gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.

Historique des gains et des recettes

NYSE:CNC Recettes, dépenses et bénéfices (USD Millions )
Date	Recettes	Les revenus	Dépenses G+A
30 Jun 24	144,064	2,823	12,455
31 Mar 24	142,800	2,735	12,573
31 Dec 23	141,266	2,702	12,407
30 Sep 23	139,354	2,444	12,130
30 Jun 23	138,101	2,713	11,934
31 Mar 23	136,941	1,483	11,704
31 Dec 22	135,999	1,202	11,366
30 Sep 22	132,756	2,014	10,892
30 Jun 22	129,228	1,860	10,562
31 Mar 22	124,181	1,497	9,888
31 Dec 21	118,573	1,347	9,376
30 Sep 21	114,130	736	9,657
30 Jun 21	111,284	720	9,995
31 Mar 21	108,158	2,461	10,461
31 Dec 20	104,280	1,808	10,276
30 Sep 20	95,764	2,029	9,529
30 Jun 20	86,523	1,556	8,301
31 Mar 20	78,105	845	7,290
31 Dec 19	70,807	1,321	6,448
30 Sep 19	68,385	1,353	6,472
30 Jun 19	65,507	1,277	6,591
31 Mar 19	61,028	1,082	6,457
31 Dec 18	56,688	900	6,331
30 Sep 18	52,618	889	5,795
30 Jun 18	48,655	1,075	5,105
31 Mar 18	47,201	1,029	4,797
31 Dec 17	45,810	828	4,370
30 Sep 17	44,870	853	4,267
30 Jun 17	43,646	796	4,303
31 Mar 17	42,468	713	4,246
31 Dec 16	37,693	562	3,900
30 Sep 16	32,839	416	3,284
30 Jun 16	28,062	360	2,719
31 Mar 16	22,948	277	2,152
31 Dec 15	21,292	356	1,990
30 Sep 15	19,854	350	1,827
30 Jun 15	18,548	339	1,699
31 Mar 15	17,102	298	1,564
31 Dec 14	15,689	268	1,424
30 Sep 14	14,134	210	1,300
30 Jun 14	12,700	179	1,183
31 Mar 14	11,475	172	1,055
31 Dec 13	10,544	161	931
30 Sep 13	9,427	209	841

Des revenus de qualité: CNC a des bénéfices de haute qualité.

Augmentation de la marge bénéficiaire: Les marges bénéficiaires nettes actuelles de CNC (2%) sont inférieures à celles de l'année dernière (2%).

Analyse des flux de trésorerie disponibles par rapport aux bénéfices

Analyse de la croissance passée des bénéfices

Tendance des revenus: Les bénéfices de CNC ont augmenté de 15.8% par an au cours des 5 dernières années.

Accélération de la croissance: La croissance des bénéfices de CNC au cours de l'année écoulée ( 4.1% ) est inférieure à sa moyenne sur 5 ans ( 15.8% par an).

Bénéfices par rapport au secteur d'activité: La croissance des bénéfices CNC au cours de l'année écoulée ( 4.1% ) n'a pas surpassé celle du secteur Healthcare 6%.

Rendement des fonds propres

ROE élevé: Le retour sur capitaux propres de CNC ( 10.3% ) est considéré comme faible.

Centene Résultats passés

Passé contrôle des critères 2/6

Informations clés

Mises à jour récentes des performances passées

Centene (NYSE:CNC) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Centene Corporation to Report Q2, 2024 Results on Jul 26, 2024

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Centene Corporation to Report Q1, 2024 Results on Apr 26, 2024

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Recent updates

Should You Be Adding Centene (NYSE:CNC) To Your Watchlist Today?

Centene (NYSE:CNC) Has Some Way To Go To Become A Multi-Bagger

Centene (NYSE:CNC) Seems To Use Debt Quite Sensibly

Centene Corporation: Strategic Market Position Amid Favorable Trends, Buy

Centene Corporation Announces the Election of Thomas R. Greco to Board of Directors

Centene (NYSE:CNC) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Investor sentiment improves as stock rises 16%

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Centene Corporation to Report Q2, 2024 Results on Jul 26, 2024

Here's Why We Think Centene (NYSE:CNC) Is Well Worth Watching

A Piece Of The Puzzle Missing From Centene Corporation's (NYSE:CNC) Share Price

Returns At Centene (NYSE:CNC) Appear To Be Weighed Down

Centene Corporation Updates Earnings Guidance for the Year 2024

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

These 4 Measures Indicate That Centene (NYSE:CNC) Is Using Debt Reasonably Well

Centene Corporation Still An Opportunity With An A-Grade Valuation

Centene Corporation, Annual General Meeting, May 14, 2024

If EPS Growth Is Important To You, Centene (NYSE:CNC) Presents An Opportunity

Centene Corporation to Report Q1, 2024 Results on Apr 26, 2024

Market Still Lacking Some Conviction On Centene Corporation (NYSE:CNC)

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Centene Corporation Increases Premium and Service Revenues Guidance for the Fiscal Year 2024

Centene Corporation Announces Appointment of Michael A. Carson as President and Chief Executive Officer of Its Medicare Business

Centene: Stay Defensive Amid Economic Uncertainty With This Low-Beta Bargain

Is Centene (NYSE:CNC) Using Too Much Debt?

Pure Health LLC completed the acquisition of Circle Health Group Limited from Centene Corporation (NYSE:CNC).

Centene Corporation to Report Fiscal Year 2023 Results on Feb 06, 2024

Centene Corporation Provides Earnings Guidance for the Fiscal Year 2024

Centene: Overlooked Healthcare Giant

Centene Corporation Announces the Appointment of Susan Smith as Chief Operating Officer, Effective January 1, 2024

Does Centene (NYSE:CNC) Deserve A Spot On Your Watchlist?

Centene: Solid Performance With Positive Outlook, But Limited Upside Potential

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Centene Corporation Provides Earnings Guidance for the Full Year 2023

Centene Corporation Names Wade Rakes as Chief Growth Officer

These 4 Measures Indicate That Centene (NYSE:CNC) Is Using Debt Reasonably Well

Decoding Centene: Why I Think It's Undervalued

Centene Corporation to Report Q3, 2023 Results on Oct 24, 2023

Pure Health LLC agreed to acquire Circle Health Group Limited from Centene Corporation (NYSE:CNC) for an enterprise value of approximately $1.2 billion.

If EPS Growth Is Important To You, Centene (NYSE:CNC) Presents An Opportunity

Centene Corporation Provides Earnings Guidance for the Full Year 2023

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Centene: Results Impress But Buyers Aren't Swarming Yet

Centene (NYSE:CNC) Has A Pretty Healthy Balance Sheet

Centene Corporation to Report Q2, 2023 Results on Jul 28, 2023

New Mountain Capital, L.L.C. acquired Apixio, Inc. from Centene Corporation.

Centene Corporation Appoints T. Susko as Its Senior Vice President and Chief Communications Officer

Centene Corporation Announces Resignation of James E. Murray as Chief Operating Officer

New Mountain Capital, L.L.C. agreed to acquire Apixio, Inc. from Centene Corporation (NYSE : CNC).

Centene to Divest AI Platform Apixio

Independent Director notifies of intention to sell stock

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Centene (NYSE:CNC) Seems To Use Debt Quite Sensibly

CEO & Director recently bought US$1.9m worth of stock

Independent Director recently bought US$503k worth of stock

Centene Corporation Provides Earnings Guidance for the Full Year 2023

Full year 2022 earnings: EPS misses analyst expectations

Centene Non-GAAP EPS of $0.86 beats by $0.02, revenue of $35.56B beats by $190M

With EPS Growth And More, Centene (NYSE:CNC) Makes An Interesting Case

Centene (NYSE:CNC) Seems To Use Debt Rather Sparingly

Centene: Once Again, With Quality, Now A 'Buy'

Centene Corporation to Report Fiscal Year 2022 Results on Feb 07, 2023

Centene Corporation Announces Management Changes

Centene appoints new leadership; Ken Fasola President of Centene, Dave Thomas CEO of Medicaid

Vivalto Santé SA completed the acquisition of Torrejon Salud, S.A. from Centene Corporation (NYSE:CNC).

Vivalto Santé SA completed the acquisition of Ribera Salud, S.A from Centene Corporation (NYSE:CNC).

Centene Corporation Appoints Monte Ford to Board of Directors

High number of new directors

An Intrinsic Calculation For Centene Corporation (NYSE:CNC) Suggests It's 50% Undervalued